126
Views
3
CrossRef citations to date
0
Altmetric
Research Article

A comparison of BGM and LLC-PK1 cells for the evaluation of nephrotoxicity

, , , , &
Pages 258-263 | Received 12 Apr 2011, Accepted 13 Jun 2011, Published online: 22 Sep 2011

References

  • Ali, B. H. (1995). Gentamicin nephrotoxicity in humans and animals: some recent research. Gen Pharmacol 26:1477–1487.
  • Babich, H., Borenfreund, E. (1993). Applications of Neutral Red cytotoxicity assay to risk assessment of aquatic contaminants: an overview. Environ Toxicol Risk Assess 1179:215–229.
  • Balakumar, P., Rohilla, A., Thangathirupathi, A. (2010). Gentamicin-induced nephrotoxicity: do we have a promising therapeutic approach to blunt it? Pharmacol Res 62:179–186.
  • Baek, S. H., Piao, X. L., Lee, U. J., Kim, H. Y., Park, J. H. (2006). Reduction of cisplatin-induced nephrotoxicity by ginsenosides isolated from processed ginseng in cultured renal tubular cells. Biol Pharmaceut Bull 29:2051–2055.
  • Borenfreund, E., Puerner, J. A. (1984). Simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/MR-90). J Tissue Cult Meth 9:7–9.
  • Carmichael, J., Degraff, W. G., Gazdar, A. F., Minna, J. D., Mitchell, J. E. (1987). Evaluation of tetrazolium-based semiautomated colorimetric assay: assessment of chemosensivity testing. Cancer Res 47:936–942.
  • Croci, L., Cozzi, L., Stacchini, A., De Medici, D., Toti, L. (1997). A rapid tissue culture for detection of okadaic acid and related compounds in mussels: Toxicon 35:223–230.
  • Dahling, D. R., Wright, B. A. (1986). Optimization of the BGM cell line culture and viral assay procedures for monitoring viruses in the environment: Appl Environ Microb 51:790–812.
  • Dehne, N., Rauen, U., de Groot, H., Lautermann, J. (2002). Involvement of the mitochondrial permeability transition in gentamicin ototoxicity: Hear Res 169:47–55.
  • Denamur, S., Van Bambeke, F., Mingeot-Leclerq, M. P., Tulkens, P. M. (2008). Apoptosis induced by aminoglycosides in LLC-PK1 cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation. Antimicrob Agents Chemother 52:2236–2238.
  • Edmondson, J. M., Armstrong, L. S., Martinez, A. O. (1988). A rapid and simple method MTT-based spectrophotometric assay for determing drug sensitivity in monolayer cultures. J Tissue Cult. Meth 11:15–17.
  • Hendriksen, C., Cussler, K., Halder, M. (2002). ECVAM’s role in the implementation of the Three Rs concept in the field of biologicals. ATLA 2002;Suppl 2:41–46.
  • Laurent, G., Kishore, B. K., Tulkens, P. M. (1990). Aminoglycoside-induced renal phospholipidosis and nephrotoxicity. Biochem Pharmacol 40:2383–2392.
  • Miyazaki, T., Sagawa, R., Honma, T., Noguchi, S., Harada, T., Komatsuda, A., et al. (2004). 73-kDa molecular chaperone HSP73 is a direct target of antibiotic gentamicin. J Biochem 279:17295–17300.
  • Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65:55–63.
  • Nagai, J., Tanaka, H., Nakanishi, N., Murakami, T., Takano, M. (2001). Role of megalin in renal handling of aminoglycosides. Am J Physiol Renal 281:F337–F344
  • Nascimento, C. R., Braga, F., Capella, L. S., Santos, O. R., Lopes, A. G., Capella, M. A. (2005). Comparative study on the effects of cyclosporin a in renal cells in culture. Nephron Exp Nephrol 99:77–86.
  • Prieto, P. (2000). ECVAM’s in-house prevalidation/validation studies in the areas of haematotoxicity, reproductive toxicity, metabolism-mediated toxicity, and epithelial barrier function. Sci Total Environ 247:349–354.
  • Repetto, G., Peso, A., Zurita, J. L. (2008). Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 3:1125–1131.
  • Romero, D., Gómez-Zapata, M., Luna, A., García-Fernandez, A. J. (2004). Comparison of cytopathological changes induced by mercury chloride exposure in renal cell lines (BGM and VERO). Environ Toxicol 17:129–141.
  • Romero-García, D., Gómez-Zapata, M., Luna, M., García-Fernandez, A. J. (2000). Comparison of two colorimetric methods in the assessment of heavy metals em cytotoxic kidney cell cultures (Comparación de dos métodos colorimétricos en la evaluación citotóxica de metales pesados em cultivos de células renales). Rev Toxicol 17:91–95.
  • Sandoval, R. M., Molitoris, B. A. (2004). Gentamicin traffics retrograde through the secretory pathway and is released in the cytosol via the endoplasmatic reticulum. Am J Physiol Renal Physiol 286:617–624.
  • Servais, H., Jossin, Y., Van Bambeke, F., Tulkens, P. M., Mingeot-Leclercq, M. P. (2006). Gentamicin causes apoptosis at low concentrations in renal LLC-PK1 cells subjected to electroporation. Antimicrob Agents Chemother 50:1213–1221.
  • Servais, H., Van Der Smissen, P., Thirion, G., Van der Essen, G., Van Bambeke, F., Tulkens, P. M., et al. (2005). Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria. Toxicol Appl Pharmacol 206:321–333.
  • Tan, C. Y., Ninove, L., Gaudart, J., Nougairede, A., Zandotti, C., Thirion-Perrier, L., et al. (2011). A retrospective overview of enterovirus infection diagnosis and molecular epidemiology in the public hospitals of Marseille, France (1985–2005). PLoS One 6:e18022.
  • Twentyman, P. R., Luscombe, M. (1987). A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56:279–285.
  • Van Der Harst, M. R., Bull, S., Laffont, C. M., Klein, W. R. (2005). Gentamicin nephrotoxicity—a comparison of in vitro findings with in vivo experiments in equines. Vet Res Commun 29:247–261.
  • Vanparys, P. (2002). ECVAM and pharmaceuticals. ATLA 30(Suppl 2):221–223.
  • Wasan, K. M., Lopez-Berenstein, G. (1994). The interactions of liposomal amphotericin B and serum lipoprotein within the biological milieu. J Drug Targ 2:373–380.
  • Waymouth, C. (1970). Osmolarity of mammalian blood and media for culture of mammalian cells. In Vitro 6:109–127.
  • Wilson, P. D. (1986). Use of cultured renal tubular cells in the study of cell injury. Miner Electroly Metab 12:71–84.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.